C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/22 (2006.01) A61K 31/495 (2006.01) A61P 3/04 (2006.01) A61P 29/00 (2006.01) C07D 241/04 (2006.01) C07D 265/30 (2006.01)
Patent
CA 2707555
The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
La présente invention concerne de nouveaux composés de formule (I), des compositions pharmaceutiques comprenant ces composés, des procédés pour leur préparation, et l'utilisation de ces composés en tant que substances mimétiques modulatrices du récepteur de la leptine dans la préparation de médicaments contre des états associés à la prise de poids, au diabète de type 2 et aux dyslipidémies.
Boyd Joseph W.
Brown Giles A.
Higginbottom Michael
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Piperazines as anti-obesity agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazines as anti-obesity agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazines as anti-obesity agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1662210